Putting the CAR-T Before the Horse: How Much Disclosure is Required Under Section 112(a) for Biotechnological Inventions?
- Published in:
- Tulane Journal of Technology & Intellectual Property, 2022, v. 24, p. 251
- By:
- Publication type:
- Article
Works matching DE "JUNO Therapeutics Inc."
Results: 4
1
2
Juno's whopping $120 million success signals new investing style.
- Published in:
- Nature Medicine, 2014, v. 20, n. 1, p. 4, doi. 10.1038/nm0114-4
- By:
- Publication type:
- Article
3
Seven days: 2-8 January 2015.
- Published in:
- Nature, 2015, v. 517, n. 7533, p. 126, doi. 10.1038/517126a
- Publication type:
- Article
4
Investor stampede for CARs.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 112, doi. 10.1038/nbt0214-112
- By:
- Publication type:
- Article